The Global Coronavirus Diagnostics market accounted for $4.64 billion in 2018 and is expected to reach $8.82 billion by 2027 growing at a CAGR of 7.4% during the forecast period. The exponential rise in cases of COVID-19 and growing healthcare spending and increasing need to protect the population from such outbreaks are the major factors propelling the market growth. However, factors such as lack of skilled nursing staff is hampering the market growth.
Based on type, the serology tests segment is going to experience lucrative growth during the forecast period as diagnostic tests are done using blood samples. Furthermore, these tests are helpful in determining patients with mild or no symptoms.
By geography, North America is likely to have experience huge demand due to growing investments in R&D activities which is further expected to create huge market opportunities for diagnostic players over the next few years.
Some of the key players profiled in the Coronavirus Diagnostics Market include Abbott, Beckman Coulter, Becton, Dickinson and Company, bioMerieux, Bio-Rad Laboratories, GSK Biologicals, Hologic, Lonza, Ortho-Clinical Diagnostics, PerkinElmer, Qiagen and Roche Diagnostics.
What the report offers:
Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.